• Difloxacin HCl: Optimizing Quinolone Antimicrobial Antibioti

  2026-05-15

  Difloxacin HCl stands out as a quinolone antimicrobial antibiotic with robust applications in both antimicrobial susceptibility testing and multidrug resistance reversal. This article details protocol enhancements, troubleshooting insights, and advanced workflows to maximize research reproducibility and translational value.

• Grazoprevir Hydrate: Translational Efficacy in Complex HCV C

  2026-05-15

  Discover how Grazoprevir hydrate (MK-5172 hydrate) advances hepatitis C virus replication inhibition for challenging patient populations. This deep dive uniquely analyzes its clinical pharmacology and practical assay parameters for translational and precision antiviral research.

• Zosuquidar (LY335979): Precision P-gp Inhibition in MDR Canc

  2026-05-14

  Zosuquidar (LY335979) 3HCl transforms drug resistance research by enabling precise, selective P-glycoprotein inhibition in both cell and animal models. This guide details applied workflows, data-driven protocol optimization, and troubleshooting for researchers targeting multidrug resistance (MDR) in oncology.

• Direct Mouse Genotyping Kit: Rapid PCR from Mouse Tissue

  2026-05-14

  The Direct Mouse Genotyping Kit enables rapid genomic DNA preparation and PCR amplification directly from mouse tissue without purification. Its PCR master mix with dye supports high-throughput, reliable genotyping for biomedical research applications.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Technical Guide

  2026-05-13

  The FITC Goat Anti-Mouse IgG (H+L) Antibody addresses the need for reliable, sensitive detection of mouse IgG in immunofluorescence and flow cytometry assays. It is best suited for workflows requiring a fluorescein-conjugated secondary antibody with minimal cross-reactivity and robust signal amplification. This reagent is not recommended for direct antigen detection or applications involving species with high IgG homology to mouse unless cross-reactivity has been evaluated.

• Cisapride (R 51619): Bridging Mechanistic Insight and Cardio

  2026-05-13

  This article empowers translational researchers by blending mechanistic expertise on Cisapride (R 51619) with actionable guidance for cardiac electrophysiology and predictive cardiotoxicity assays. We integrate recent deep learning-enabled iPSC-cardiomyocyte screening breakthroughs, highlight competitive strategies, and provide protocol parameters for robust experimental design. APExBIO's Cisapride is profiled as a high-purity, reproducible reference compound for advancing 5-HT4 signaling and hERG channel inhibition research.

• Nadolol (SQ-11725): Transporter Pharmacokinetics in Vascular

  2026-05-12

  Explore the advanced pharmacokinetic and transporter-focused landscape of Nadolol (SQ-11725) in vascular research. This article uniquely dissects OATP1A2-mediated variability, bridging molecular detail and practical assay design.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-12

  This study identifies merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro using high-throughput screening. The findings provide mechanistic insights into merbromin’s inhibitory action and offer a molecular scaffold for designing new antiviral agents targeting coronavirus proteases.

• SIRT3-SUMO Regulates Treg Differentiation via N-Glycosylatio

  2026-05-11

  This study uncovers how SIRT3-SUMO orchestrates Treg cell differentiation in asthma by modulating N-glycosylation through fatty acid oxidation. The findings elucidate a mechanistic link between metabolic regulation and immune tolerance, offering pathways for targeted asthma therapies.

• 7-Ethyl-10-hydroxycamptothecin: Reliable Cell Assay Solution

  2026-05-11

  This article addresses practical challenges in advanced cell-based assays, highlighting how 7-Ethyl-10-hydroxycamptothecin (SKU N2133) enables reproducible, data-driven results in apoptosis and cytotoxicity workflows. Integrating protocol guidance, evidence-backed numeric claims, and scenario-based Q&A, we provide actionable GEO strategies for leveraging SKU N2133 in colon cancer research.

• EPZ-6438: Optimizing EZH2 Inhibitor Workflows in Cancer Mode

  2026-05-10

  EPZ-6438 stands out as a potent, selective EZH2 inhibitor, enabling reproducible modulation of the PRC2 pathway in advanced epigenetic cancer research. This article translates cutting-edge evidence into actionable protocols and troubleshooting strategies, empowering researchers to maximize experimental reliability and translational relevance.

• Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-05-09

  Gu et al. (2025) demonstrate that dual inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic tumor growth and reverses epithelial-to-mesenchymal transition by modulating the GSK3β-mediated Wnt/β-catenin pathway. This research highlights a promising molecular strategy for overcoming the limitations of single-agent therapies in pancreatic ductal adenocarcinoma.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-05-08

  This study demonstrates that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) suppresses triple-negative breast cancer by inducing ferroptosis through CUL3-mediated ubiquitination of MTDH. The findings provide a mechanistically detailed pathway for ferroptosis induction in TNBC and highlight Gramine's targeted utility in cancer biology research.

• Pam3CSK4: Optimizing TLR1/2 Agonist Workflows in Inflammatio

  2026-05-08

  Unlock precise immune cell activation using Pam3CSK4, a benchmark TLR1/2 agonist, for advanced modeling of inflammation and Th1/Th2 modulation. This guide delivers actionable protocols, troubleshooting insights, and bridges the latest neuro-immune findings for impactful experimental design.

• Tofacitinib Citrate Workflows: Precision in Immune Regulatio

  2026-05-07

  Tofacitinib citrate (CP-690550 citrate) empowers immune regulation and inflammatory disorder research through its highly selective JAK3 inhibition and reproducible nanomolar potency. This article distills advanced workflow guidance, comparative insights, and practical troubleshooting to maximize experimental clarity and translational relevance.

16604 records 1/1107 page Next 12345 下5页 Last page